ResearcherUniversity of UlsterNo recent work listed
Jinhui Gao
Matched on ORCID iD 0000-0001-9588-7561; OpenAlex author ID A5010154875. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2020: 1 paper · 2021: 2 papers
Papers 3
- Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2021.06.003↗
- Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatmen… Co-author DOI 10.1016/j.ejpb.2021.05.018↗
- An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic cancer. Co-author DOI 10.1016/j.ejpb.2020.10.012↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Keiran A. Logan · 3 shared papers, 2020–2021 · strength 0.36
- Paper Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation… DOI 10.1016/j.ejpb.2021.05.018↗
- Paper Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer. DOI 10.1016/j.canlet.2021.06.003↗
- Paper An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic can… DOI 10.1016/j.ejpb.2020.10.012↗
- Mark Taylor · 3 shared papers, 2020–2021 · strength 0.36
- Paper Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation… DOI 10.1016/j.ejpb.2021.05.018↗
- Paper Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer. DOI 10.1016/j.canlet.2021.06.003↗
- Paper An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic can… DOI 10.1016/j.ejpb.2020.10.012↗
- A. P. McHale · 3 shared papers, 2020–2021 · strength 0.36
- Paper Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation… DOI 10.1016/j.ejpb.2021.05.018↗
- Paper Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer. DOI 10.1016/j.canlet.2021.06.003↗
- Paper An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic can… DOI 10.1016/j.ejpb.2020.10.012↗
- Heather Nesbitt · 3 shared papers, 2020–2021 · strength 0.36
- Paper Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation… DOI 10.1016/j.ejpb.2021.05.018↗
- Paper Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer. DOI 10.1016/j.canlet.2021.06.003↗
- Paper An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic can… DOI 10.1016/j.ejpb.2020.10.012↗
- John F. Callan · 2 shared papers, 2020–2021 · strength 0.23
- Paper Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer. DOI 10.1016/j.canlet.2021.06.003↗
- Paper An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic can… DOI 10.1016/j.ejpb.2020.10.012↗
- John F. Callan · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.